Eyepoint Pharmaceuticals shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.1M | 143k | 7.99 |
| 2024-06-30 | $1.2M | 135k | 8.70 |
| 2024-03-31 | $2.1M | 100k | 20.67 |
| 2023-12-31 | $1.8M | 78k | 23.11 |
| 2023-09-30 | $572k | 72k | 7.99 |
| 2023-06-30 | $623k | 72k | 8.70 |
| 2023-03-31 | $210k | 71k | 2.94 |
| 2022-12-31 | $250k | 71k | 3.50 |
| 2022-09-30 | $545k | 69k | 7.92 |
| 2022-06-30 | $544k | 69k | 7.88 |
| 2022-03-31 | $818k | 67k | 12.16 |
| 2021-12-31 | $664k | 54k | 12.25 |
| 2021-09-30 | $545k | 52k | 10.43 |
| 2021-06-30 | $470k | 52k | 8.99 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management